Eastwood Bio-Medical Canada Inc.
EBM.V
TSX
| 07/31/2025 | 04/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 69.07% | -64.26% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 69.07% | -64.26% | |||
| Cost of Revenue | 1.81% | -29.34% | |||
| Gross Profit | 139.92% | -76.50% | |||
| SG&A Expenses | -14.44% | 15.34% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -11.46% | -15.03% | |||
| Operating Income | 56.29% | -264.66% | |||
| Income Before Tax | 61.87% | -280.69% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 61.87% | -280.69% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 61.87% | -280.69% | |||
| EBIT | 56.29% | -264.66% | |||
| EBITDA | 56.29% | -2,040.00% | |||
| EPS Basic | 62.50% | -300.00% | |||
| Normalized Basic EPS | 60.00% | -233.33% | |||
| EPS Diluted | 62.50% | -300.00% | |||
| Normalized Diluted EPS | 60.00% | -233.33% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||